Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not

Recruiting now · Not applicable

Conditions studied: Sarcopenia

In brief

The three-year interventional study has the following objectives: The study aims to assess the prevalence of sarcopenia in menopausal women receiving hormone replacement therapy or not compared with pre-menopausal women. The study population will be divided into groups according to the intake or not of hormonal therapy of menopause as per normal clinical practice and the menopausal state: GROUP A - menopausal patient taking hormone therapy GROUP B - menopausal patient not taking hormone therapy GROUP C - pre-menopausal patients who do not take hormonal products The primary objective is to compare the strength and muscle mass outcomes of HRT in menopausal women compared with those who do not use it and women in pre-menopausal age. Survey methods such as SARC-F, Handgrip test, Chair stand test and bio impedance

Key facts

Study ID

NCT06792201

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

180

Starts

2021-06-14

Expected to finish

2026-06-14

Last updated by the study team

2025-01-24

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patients attending the O.U. of Gynecology and Pathophysiology of Human Reproduction in menopause who take or do not take hormone replacement therapy at the time of visit as normal clinical practice and women in pre-menopause.
• Patients for whom informed consent has been obtained.

You may not qualify if…

• no exclusion criteria are provided

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.